MDT Jan 2025 70.000 call
| Previous Close | 12.95 |
| Open | 12.95 |
| Bid | 12.65 |
| Ask | 14.95 |
| Strike | 70.00 |
| Expire Date | 2025-01-17 |
| Day's Range | 12.95 - 12.95 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 407 |
ACCESSWIREMedtronic: 'Pivotal Moment' in Women's Heart Health
Female-specific results from first-of-its-kind clinical trial NORTHAMPTON, MA / ACCESSWIRE / May 1, 2024 / Teaching first graders takes a lot of energy. So when Julia Garcia started feeling worn out, teaching became extremely difficult. "I got very ...
ZacksMedtronic (MDT) Rises Higher Than Market: Key Facts
Medtronic (MDT) closed at $80.86 in the latest trading session, marking a +1.4% move from the prior day.
CNW GroupMedtronic receives FDA approval for Inceptiv™ closed-loop spinal cord stimulator
Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that the U.S. Food and Drug Administration (FDA) has approved the Inceptiv™ closed-loop rechargeable spinal cord stimulator (SCS) for the treatment of chronic pain. Inceptiv is the first Medtronic SCS device to offer a closed-loop feature that senses biological signals along the spinal cord and automatically adjusts stimulation in real time, keeping therapy in harmony with the motions of daily life.
